Patients with multiple myeloma and CKD: Should we really hold off on bispecific therapy in this subgroup?
Year: 2025
Type: conference-abstract
Source: Blood
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4417002105
